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Summary: The fluorimetric and microbiological methods for the determination of serum and urine cephalexin were
compared with the aid of coded samples in two different laboratories.
The coefficient of correlation between the two methods for serum cephalexin was 0.94.
At urine cephalexin concentrations above 0.5 g/1, the coefficient of correlation between two methods was 0.83.
At lower concentrations (0.5 g/1), the coefficient of correlation was 0.72.
It was concluded that the tested methods are comparable, equally sensitive and precise.
Korrelation zwischen fluorimetrischer und mikrobiologischer Bestimmungsmethode für Cephalexin in Serum und Harn
Zusammenfassung: Die fluorimetrische und mikrobiologische Bestimmungsmethode für Cephalexin in Serum und
Harn wurde mit Proben bekannter Konzentration in zwei verschiedenen Laboratorien verglichen. Der Korrelations-
koeffizient für die Cephalexinbestimmung in Serum betrug r = 0,94. Für Cephalexinkonzentrationen im Harn über
0,5 g/l betrug der Korrelationskoeffizient r = 0,83, für Konzentrationen darunter r = 0,72. Die geprüften Methoden
sind vergleichbar, gleich empfindlich und präzise.
Introduction
Cephalexin is a very useful antibiotic which is present
in many countries in oral formulations. The pharmaco-
kineties of cephalexin and the biöavailability of its oral
preparations have therefore been the subject of various
studies (1-5).
The analytical methods for cephalexin determination in
biological fluids follow the development in analytical
methodology. So far, microbiological (6—10), spectro-
scopic (11, 12), fluorimetric (13,14) and high pressure
liquid Chromatographie (15, 16) methods have been
described. An evaluation of these methods is difficult
from the existing data in the literature.
We therefore evaluated the fluorimetric and micro-
biological methods by determination of serum and urine
cephalexin levels with both methods on the same samples.
Material and Methods
Two different laboratories determined cephalexin concentrations
in coded samples of urine and serum.
Fluorimetric method,
The fluorimetric measurements were performed on a Perkin
Elmer fluorimeter M 850.
All chemicals were of analytical grade purchased from "Kemika",
Zagreb.
Procedure
0.6 mol/1 Trifluoracetic acid (1 ml) was added to serum or stand-
ard (1 ml) in a centrifuge tube and the content was vortexed for
5 s and centrifuged for 5 min at 4000 rev/min. The supernatant
(1 ml) was transferred to a clean glass tube which contained
2 mol/1 NaOH (0.5 ml). The mixture was incubated for 10 min
at room temperature and 2 mol/i hydrochloric acid (0.5 ml) and
70 Mmol/1 solution of HgCl2 (0.5 ml) was added and the tube
was incubated for 5 min at room temperature. A 0.9 mol/1
formaldehyde solution mMdlvaine^s citrate-phosphate buffer
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pH 6.5 (3.0 ml) was added and the tube was incubated 45 min
at 37 °C. The fluorescence of the cooled reaction mixture was
measured at 425 nm with excitation at 345 nm.
Fluorimetric method for urine cephalexin determination
For concentrations between 0.2 and 5 g/1:
Urine (0.1 ml) was added to a glass tube which contained
distilled water (10 ml) and it was vortexed for a few seconds.
The diluted sample (1 ml) was transferred to a clean glass tube
and the 2 mol/1 sodium hydroxide solution (0.5 ml) was added.
The further procedure was'identical to the serum method.
For concentrations between 0 and 200 mg/1:
The sample was diluted with water in a ratio 1:10.
Microbiological method
Materials
"Oxford" Sampler Micropipetting System, 300 1; Nutrient agar
medium, prepared as direct in Code of Federal Regulations,
Food and Drug Administration, 1973 & 141.103. Culture
media (b) 1. -corresponds to Medium A, BP, 73.
A suspension of the organism, Sarcina lutea ATCC 9341, was
prepared as directed in CFR, FDA, 1973. & 141.104.
Serum level determination
The stock solution of cephalexin working standard was prepared
with phosphate buffer pH 6. This solution was further diluted to
the concentrations ranging from 0.2-0.4 mg/1, using a mixture
of a pooled human serum and the phosphate buffer in a ratio
corresponding to the sample dilution. Each serum sample was
diluted with the phosphate buffer to the concentration of
cephalexin that is supposed to fall in the range of the standard
curve.
The melted nutrient agar medium was inoculated with the test
organism suspension that was previously adjusted to a suitable
density. The inoculated medium was spilled on large rectangular
plates. Holes 12 mm in diameter were bored in the agar medium.
Portions of 300 ìÀ each of standard and sample solutions were
introduced into the holes. The plates were incubated for 16 to
18 hours at 32-35 °C, and the zone diameters were measured
with an accuracy of 0.1 mm. The cephalexin serum level was
calculated by means of the data obtained from standard curve.
Urine level determination
The procedure was the same as described for serum level deter-
mination except the standard solution were prepared and diluted
in the phosphate buffer. The accuracy of the analysis was tested
by adding known amounts of drug to twenty plasma or urine
samples at different concentrations. In the microbiological
method, reproducibility of results calculated as the standard
deviation of zone diameters for each point of the standard solu-
tions and the samples respectively, was not more than 5.0
(zone diameters were measured in mm X 10).
The intra and interassay coefficients of variation, the regression
and correlation coefficients were calculated with the prepared
programmes from Hewlett Packard on a Hewlett Packard calcula-
tor HP-65.
Results
The limit of detection in the fluorimetric method was
0.1 mg/1. The standard curve was linear in the range of
0-40 mg/1 for serum, 0-250 mg/1 for ten fold diluted
urine and 200-3000 mg/1 for hundred fold diluted urine
samples.
Table 1 shows inter- and intra-assay coefficients of varia-
tion at different cephalexin concentrations in serum
and urine with the fluorimetric method (20 determina-
tion of each concentrations). The coefficients of varia-
tion are satisfactory in all examined concentration
ranges. The intra-assay coefficients of variation in the
microbiological method were lower than 5% in all ranges
of the serum or urine cephalexin concentrations. In the
microbiological method, the range of linearity of the
dose-resonse curve was 0.15—1.2 mg/1 with a limit of
detection of 0.03 mg/1.
Figure 1 compares the results of the cephalexin serum
level determinations between two methods. The regres-
sion is represented by the equation Cfiuorimetric = 0.32 +
+ 1.06 ^microbiological· The correlation coefficient be-
tween the methods was 0.94, s^y 3.33, s0 0.39 and
Sj 0.03. Figure 2 represents the correlation between the
results of the urine level determination in the concentra-
tion range 0-200 mg/1. The regression between two
methods is described by equation:
^fluorimetric = H + 1-02 cmicrobiological. The correlation
coefficient was 0.72, s^y 27.7, SQ 4.85 and sl 0.13.
Tab. 1. The inter- and intra-assay coefficients of variation in the
fluorimetric method for serum and urine cephalexin
determination.
Number of determination in the series: 20 each
Number of series: 2 each.
Spiked
samples
Serum
Urine
Concentration
(mg/1)
0.84
1.48
6.5
10.3
22.2
1.1
30.0
120.0
220.0
920.0
2400.0
Iritra-assay
CV
(%)
5.3
6.2
2.0
1.6
1.8
13.2
8.2
5.2
7.1
2.5
2.2
Inter-assay
CV
(%)
9.9
8.3
3.1
4.2
2.5
17.3
7.1
6.7
3.7
30-
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Fig. 1. Correlation between fluorimetric and microbiological
methods for serum cephalexin determination^
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Fig. 2. The correlation between fluorimetric and microbiological
methods for urine cephaiexin determination at cephalexin
concentrations below 200 mg/l.
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Fig. 3. The correlation between fluorimetric and microbiological
methods for urine cephalexin determination at cephaiexin
concentrations over 200 mg/l.
In figure 3 the results of the cephalexin urine level
measurements in the concentration range 200-
2500 mg/l have been compared. The regression is rep-
resented with the equation ^fluorimetric = 170 +
1-06 ^microbiological- The coefficient of correlation was
0.83, sx>y 413.9, s0 240 and sl 0.19.
Discussion
The microbiological method (6-10) for cephalexin
determination in biological fluids is the most widely used
and useful. Fluorimetry is a relatively recent method
(14) for cephalexin. This method is based on the meas-
urements of pyrrolidone products of cephalexin re-
arrangement. The -lactam ring is cleaved with sodium
hydroxide. Reaction with formaldehyde produces a
phenylglycine group which cyclises with the (3-lactam
carboxyl to form the pyrrolidone ring. In a report from
Barbhayia (14) the cyclisation is catalysed by mercury
ions. The reaction recovery is dependent on reaction pH
and-on the penicillin or cephalosporin structure.
The fluorimetric method is specific only for substances
with an á-amino group in the N-terrninal position in
penicillins and cephalosporins. Therefore only substances
with an á-amino group, with electronic system such
phenyl or phenoxy, and with the possibility of the
cyclisation to the pyrrolidone ring may interfere with
this method. Cephalexin is not metabolised in man (3).
The inter- and intra-assay coefficients of variation are
satisfactory in both methods for serum and for urine.
The sensitivity and accuracy are similar in the examined
methods. The correlation between two methods for
serum cephalexin is very good. It is very important to
note that in urine excreted in the first 6 hours the con-
centrations are higher than 500 mg/l. In this concentra-
tion range, the correlation between the two methods
for urine cephalexin determination is good.
The methods are comparable in the normal range of
cephalexin concentrations andjsimilar in sensitivity
and accuracy. The results obtained with the fluorimetric
method are slightly higher.
The value of the two methods will not be discussed here
with respect to the differences in the pharmacokinetic
of cephalexin; the bioavailability calculations for
cephalexin preparations will be presented in another
paper.
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